Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.
about
Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantationEndocrinopathies in survivors of childhood neoplasiaDelivering care to long-term adult survivors of hematopoietic cell transplantation.Late effects of blood and marrow transplantation.How I treat late effects in adults after allogeneic stem cell transplantation.Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemiaNCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.Autoimmune thyroid disease following alemtuzumab therapy and hematopoietic cell transplantation in pediatric patients with sickle cell disease.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediaScreening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: a childhood cancer survivor study reportLate Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.Poor growth, thyroid dysfunction and vitamin D deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adultsEndocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell TransplantationProlonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignanciesEndocrine complications after busulphan and cyclophosphamide based hematopoietic stem cell transplant: A single tertiary care centre experienceLate thyroid complications in survivors of childhood acute leukemia. An L.E.A. study.Late complications after hematopoietic stem cell transplantation.Reviewing the follow-up care of pediatric patients' status post-hematopoietic stem cell transplantation for the primary care pediatrician.Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.Childhood to adult transition and long-term follow-up after blood and marrow transplantation.Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation.Metabolic syndrome induced by anticancer treatment in childhood cancer survivors.A review of late complications of allogeneic hematopoietic stem cell transplantations.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationRecommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Risk factors for short term thyroid dysfunction after hematopoietic stem cell transplantation in children.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study.Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells.Thyroid nodules and long-term follow-up among childhood cancer survivors who underwent hematopoietic stem cell transplantation.Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.
P2860
Q26827226-8F693483-4AFE-4F60-9A28-0BB96A8C3753Q27009171-AB4B1836-F212-4695-8583-51FE22E675BDQ27021501-45B020F4-DF12-41BF-AE74-A06E6B465FFBQ33574136-36228D7C-66A7-4B6F-AFC9-5C964E85F6FFQ34707208-3DF5901F-FC53-4CBE-88B4-D3ED59D0F13BQ35153813-5442B579-4EE4-4FF9-8C66-91CF35B057B1Q35563274-60C4F682-9C76-4B98-8FD2-4DBB513CC942Q35634116-EBDA4EEC-A1EB-49C1-8911-B76C826747DCQ35757247-37B8CD48-CF0C-47C5-8A01-04FB44A33DF9Q35762578-E3215219-DE0F-42BB-8C72-0DF0632ED1A2Q35815806-D410D5B9-B986-4AFC-B388-0226138E0106Q36218406-B1A2771E-5509-4F99-9B13-F6EC7C35CAAFQ36783762-1A542AA5-91C2-4366-9C4C-C23D76AB67E7Q37072004-640A7EA2-6C55-4250-B498-678725882655Q37081520-DCB00DAC-1AA8-4BA6-A138-77D66C5D5CDEQ37158315-B6F67210-73A0-4CEC-98C7-83239A932F01Q37201666-00E5EA4C-702B-4599-A258-43D887A51F88Q37237908-24A73448-1368-4E22-9E01-1184FF41B4C7Q37810122-F5A0D0CC-9385-46EE-B12F-6EA9FF025BA0Q38096959-4502D638-35AE-4868-A285-AD82E2C4312BQ38103184-2E8BB6D1-B4FC-425F-9596-2ADE883F0655Q38545052-A1209EBE-04AE-4111-922A-0389257B9125Q38628809-C7583725-BFDB-45BF-9D5C-81F25340CDF5Q38661120-DAE8CC9B-EF7B-47D6-B8E8-EC184D32BE3BQ38867148-F7B4C1C7-4550-440D-A667-7FCD30FE3FE6Q39424937-F1C9CEE2-A73E-4968-8C72-44768AD59074Q40115697-500E30AF-4AF5-4C41-937F-C26CAC764F35Q42111313-38DA2291-84AC-48E6-9949-6891EAD34C07Q42230889-96526BA7-E47C-4F42-A2BF-B8D47B2D4634Q42805890-43ACD9C9-E4A9-46D8-B7A9-90D37B632AC9Q43218850-C24BDCDB-1166-4565-BA7A-229C1F1CA654Q47865904-A007BC19-F887-41E0-9531-7546142D1E80Q47959792-F29CCB9E-5D3D-4B12-84B5-9484A4C69203Q48085574-EBD2B95C-05C1-470D-BC49-0A4C3D6EA34CQ53941832-8B0FCABC-B533-496B-87BE-C4C3D6D7B524Q54972139-0CE7B732-1C93-4ADF-8F7C-9EA376CF4F25Q55638215-A1ABA164-4E5B-48B4-9C6A-1036EE68E314
P2860
Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thyroid function following hem ...... hildren: 30 years' experience.
@en
Thyroid function following hem ...... hildren: 30 years' experience.
@nl
type
label
Thyroid function following hem ...... hildren: 30 years' experience.
@en
Thyroid function following hem ...... hildren: 30 years' experience.
@nl
prefLabel
Thyroid function following hem ...... hildren: 30 years' experience.
@en
Thyroid function following hem ...... hildren: 30 years' experience.
@nl
P2093
P2860
P50
P1433
P1476
Thyroid function following hem ...... hildren: 30 years' experience.
@en
P2093
Ann E Woolfrey
Jean E Sanders
Paul A Carpenter
Paul A Hoffmeister
P2860
P304
P356
10.1182/BLOOD-2008-08-173005
P407
P577
2008-10-06T00:00:00Z